Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000350738 | SCV000417803 | benign | Familial hemiplegic migraine | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000386585 | SCV000417804 | benign | Epilepsy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001529924 | SCV001869140 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002480179 | SCV002795640 | benign | Migraine, familial hemiplegic, 3; Severe myoclonic epilepsy in infancy; Generalized epilepsy with febrile seizures plus, type 2; Developmental and epileptic encephalopathy 6B | 2021-12-23 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV001727688 | SCV005087516 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 62% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 58. Only high quality variants are reported. |
Diagnostic Laboratory, |
RCV001529924 | SCV001744258 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529924 | SCV001929786 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727688 | SCV001970933 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001727688 | SCV002036599 | benign | not specified | no assertion criteria provided | clinical testing |